Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
69 Cards in this Set
- Front
- Back
Define dementia
|
1. Memory impairment
2. At least one: aphasia, apraxia, agnosia, executive dysfunction |
|
Onset of:
Alzheimer's disease Vascular dementia |
Alzheimer's - Gradual
Vascular dementia - Acute |
|
Major symptoms of Dementia with Lewy bodies
|
1. Fluctuating cognition with pronounced variations in attention and alertness
2. Recurrent visual hallucinations 3. Spontaneous motor features of Parkinsonism |
|
3 Reversible causes of dementia
|
1. Normal pressure hydrocephalus
2. Vitamin B-12 deficiency 3. Brain tumor (if operable) |
|
The Components of the Confusion Assessment Method (for delirium diagnosis)
|
1. Acute onset and fluctuating course
2. Inattention 3. Disorganized thinking 4. Altered level of consciousness -Must have 1 and 2, then must have either 3 OR 4 |
|
7 Drugs that commonly precipitate delirium
|
1. Sedative hypnotics
2. Antidepressants 3. Anticholinergics 4. Opioids 5. Anticonvulsants 6. Antiparkinsonian drugs 7. H-2 blockers |
|
MMSE scores
|
Mini-Mental Status Exam is based on a 30 point scale, scores below 24 are suggestive of dementia
|
|
Definite Risk factors of Alzheimer's Disease
|
1. Age
2. Family history 3. Identified apo E mutations/polymorphisms 4. Head trauma 5. Downs syndrome |
|
Brain autopsy of:
Alzheimer's Disease Vascular Dementia Dementia with Lewy Bodies |
Alzheimer's brains show plaques and tangles
Vascular dementia brains show multiple CVAs Dementia with Lewy bodies brains show Lewy bodies in the deep corical layers |
|
2 drug classes that should be eliminated in elderly patients at risk for dementia
|
1. Antichoinergics
2. Benzodiazepines |
|
Drugs which need to be evaluated in the elderly
|
1. Tricyclic antidepressants
2. H2 blockers 3. Antihistamines 4. Scopolamine 5. Benzodiazepines 6. Phenytoin 7. Phenobarbital 8. Ethanol 9. Bromocriptine 10. Antiarrhythmics 11. Antipsychotics 12. Lithium 13. Beta blockers 14. NSAIDS 15. Digoxin 16. Carbamazepine 17. Antispasmodics 18. Corticosteroids |
|
What 4 classes of drugs are used as general strategies to treat dementia?
|
1. Antiplatelet drugs
2. Statins 3. Anticoagulation 4. Antihypertensives |
|
Name the Cholinesterase inhibitors.
|
1. Aricept - donepezil
2. Exelon - rivastigmine 3. Razadyne - galantamine |
|
Dosing scheme of donepezil (Aricept)
|
Initial 5 mg daily, increase to 10 mg daily in 4-6 weeks
|
|
Dosing scheme for Exelon (rivastigmine)
|
Initial 1.5 mg BID with food, increase by 1.5 mg every 2-4 weeks to 6 mg total daily dose
|
|
Dosing scheme for Exelon Patch (rivastigmine)
|
Apply 4.6 mg patch daily, increase to 9.5 mg after 4 weeks
|
|
Dosing scheme for Razadyne (galantamine)
|
4 mg BID with meals (8 mg daily for ER), increase by 8 mg daily every 4 weeks to 24 mg total daily dose
|
|
Special info about Cholinesterase inhibitors
|
Rivastigmine has no hepatic metabolism, unlike the others
Rivastigmine patch has reduced incidence of side effects compared to oral Galantamine requires renal dosing adjustment |
|
Adverse effects of Cholinesterase inhibitors
|
1. GI: nausea, vomiting, diarrhea, increase GI bleeding esp if used with NSAIDS
2. CNS: headache, insomnia, dizziness 3. Cardiac: bradycardia, orthostatic hypotension, syncope 4. GU: incontinence |
|
Dosing scheme for memantine (Namenda)
|
initial 5 mg daily, increase by 5 mg increments up to the target dose of 10 mg BID or 20 mg daily
|
|
Adverse effects of memantine
|
Renal dosing adjustment is required
Effects include agitation, urinary incontinence, insomnia, diarrhea, confusion |
|
What are some miscellaneous agents used for dementia treatment?
|
1. vitamin E
2. gingko biloba 3. curcumin 4. amyliod antibodies 5. abatacept (Enbrel) |
|
What are some non-pharmacologic treatment methods for dementia?
|
1. Environmental manipulation
2. Planned daily acitivities 3. Validation therapy 4. Stimulation therapy 5. Patient-centered care |
|
What are the main drugs used for the treatment of non-cognitive symptoms of dementia?
|
1. Atypical antipsychotics (too many adverse effects)
2. Cholinesterase inhibitors 3. SSRI's 4. Antiepileptic agents |
|
Treatment of anxiety in dementia patients
|
Try buspirone or an SSRI/SNRI. Gabapentin has also been useful. Limit benzo's.
|
|
Treatment of paranoia in dementia patients
|
Antipsychotics are indicated for moderate to severe symptoms
|
|
Treatment of hallucinations in dementia patients
|
Risperidone, olanzepine or quetiapine can be used at very low doses
|
|
Treatment of insomnia in dementia patients
|
Start with non-pharmacologic treatment, sleep hygeine techniques. Melatonin at bedtime may help normalize sleep-wake cycles.
|
|
Treatment of depression in dementia patients
|
Use SSRI or mirtazepine
|
|
Treament of sundowning in dementia patients
|
Low doses of atypical antipsychotic agents
|
|
Which drugs can cause drug-induced parkinsonism (tardive dyskinesia)?
|
1. Antipsychotics (phenothiazines, butyrophenones)
2. Antiemetics (metoclopramide, prochlorperazine) |
|
What are the hallmark features of Parkinson's Disease?
|
1. Tremor
2. Rigidity 3. Bradykinesia 4. Postural instability |
|
What is the goal of Parkinson drug therapy?
|
The goal is to restore dopaminergic/cholinergic balance via dopamine stimulus and/or muscarinic cholinergic antagonism
|
|
What ratio carbidopa/levodopa should patient be started on? When should this change?
|
Patient should be started on a 1:4 ratio. Once levodopa requirements exceed 750 mg/day, switch to the 10/100 tablet.
|
|
What are the dosing guidelines for carbidopa/levodopa?
|
Initiate with 25/100 tablet given 2-3 times per day. Dosage may be increased by one 25/100 tablet daily or QOD as tolerated. Avoid taking with protein.
|
|
What is the ODT form of carbidopa/levodopa?
|
Parcopa
|
|
What are the side effects of carbidopa/levodopa?
|
Initial side effects are mostly peripheral. These include N/V, orthostatic hypotension, tachycardia/cardia arrhythmias, PUD
Over time, central effects take hold. These include dyskinesias, response fluctuations (motor complications), psychiatric complications, mental status changes including confusion, hallucinations, and psychosis. |
|
What can be done for "wearing off" or "end-of-dose" with levodopa therapy?
|
Improved by shortening dosing interval, using extended release products, a dopamine agonist, MAO-B inhibitor, or COMT inhibitor.
|
|
What can be done for the "on-off" effect of levodopa therapy?
|
May benefit from increasing carbidopa/levodopa, dopamine agonist, MAO-B inhibitor, or alteration in dietary habits.
|
|
What can be done for abnormal involuntary movements with levodopa therapy?
|
Dose reduction or "smoothing" of levodopa-derived dopaminergic stimulation required.
|
|
What is "smoothing" of levodopa therapy? How is this achieved?
|
Smoothing is reducing peak levodopa concentrations and increasing trough concentrations. It is achieved by shortening dosing interval, using CR products, combining IR and CR, and/or adding a COMT inhibitor (with levodopa dose reduction).
|
|
What are the major drug interactions with carbidopa/levodopa?
|
1. Pyridoxine decreases the effectiveness of levodopa; this effect is reversed when used with carbidopa though.
2. Drugs that possess dopamine antagonist activity (phenothiazines, metoclopramide) 3. Ferrous sulfate forms chelation complex decreasing levodopa absorption 4. Anticholinergics delay gastric emptying. 5. MAO inhibitors cause build up of metabolites |
|
Contraindications of carbidopa/levodopa
|
1. history of melanoma
2. concomitant non-specific MAO inhibitor within prior 14 days 3. narrow-angle glaucoma 4. Precautions with MI, arrhythmias, asthma, wide-angle glaucoma, PUD |
|
What is the main ergot dopamine agonist?
|
bromocriptine (Parlodel)
|
|
What is the most concerning side effect of bromocriptine?
|
Valvular heart disease
Others include N/V/anorexia, hallucinations, OH, decreased prolactin |
|
How does bromocriptine work?
|
stimulates D2 and antagonizes D1
|
|
What are the non-ergot dopamine agonists?
|
ropinirole (Requip)
pramipexole (Mirapex) |
|
How do ropinirole and pramipexole work?
|
stimulate D2 and D3 receptor sites
|
|
How are ropinirole and pramipexole eliminated?
|
1. ropinirole is eliminated via hepatic metabolism
2. pramipexole is eliminated renally |
|
Dosing schedule for ropinirole
|
initial 0.25 mg TID, usual dose is 3-24 mg/day divided TID
|
|
Dosing schedule for pramipexole
|
initiate at 0.125 mg TID, usual dose is 1.5-4.5 mg/day divided TID
|
|
Pramipexole dosing in renal failure
|
CrCl over 60 start with 0.125 mg TID with a max dose of 1.5 mg TID
CrCl 35-59 start with 0.125 mg BID with a max dose of 1.5 mg BID CrCl 15-34 start with 0.125 mg daily with a max dose of 1.5 mg daily |
|
How does rotigotine (Neupro) work?
|
stimulates D1, D2, and D3 receptors
|
|
What are the side effects of rotigotine (Neupro)?
|
GI: nausea, vomiting
application site reations fatigue and somnolence |
|
How does apomorphine (Apokyn) work?
|
It stimulates D2 receptors. It is used to treat acute episodes of hypomobility (the off side of 'on-off') associated with advanced Parkinson's disease
|
|
What are the side effects of apomorphine (Apokyn)?
|
Due to emetic properties, must start patient on antiemetic at least 3 days before initiating apomorphine. Hypotension is also a risk.
|
|
What are the main COMT inhibitors?
|
1. tolcapone
2. entacapone |
|
How do COMT inhibitors work?
|
They increase levodopa bioavailability and half-life. They reduce 'off' time of 'wearing-off' phenomena. Levodopa dose needs to be decreased by 30%.
|
|
What are the side effects of entacapone?
|
1. Dopaminergic: dyskinesias, N/V/D/A, OH, HA
2. Increased liver transaminases that requires monitoring, rarely used anymore due to this |
|
How is entacapone metabolized?
|
Metabolized through glucuronidation (no liver problems makes it the more common COMT inhibitor)
|
|
What is the levodopa/carbidopa/entacapone combination?
|
Stalevo
|
|
What are the main MAO Type B inhibitors?
|
1. Selegiline
2. Rasagiline |
|
How do MAO Type B inhibitors work?
|
They prevent degradation of dopamine in the brain. Must reduce dose of levodopa by 10-30%.
|
|
Drug interactions with selegiline
|
1. Risk of serotonin syndrome (meperidine is contraindicated)
|
|
Drug interactions with rasagiline
|
1. Metabolism through CYP1A2 is inhibited by many drugs (cimetidine, macrolides, estrogen, ketoconazole, levofloxacin, paroxetine)
2. Serotonin syndrome (meperidine, tramadol, methadone, propoxyphene, mirtazapine, etc.) 3. Contraindicated with MAOI's 4. Watch tyramine over 75 mg/day |
|
What is amantadine used for?
|
Improves tremor, rigidity, bradykinesia; especially tremor
|
|
Amantadine dosing
|
Initiate with 100 mg daily with breakfast, increase to 100 mg BID with breakfast and lunch on day 5 of therapy (early dosing due to insomnia); dosage adjustment with renal impairment
|
|
Side effects of amantadine
|
Cardiac: OH, edema, CHF exacerbation
CNS: insomnia, confusion, hallucinations GI: N/V/D Not used too often due to these side effects |
|
Anticholinergic use in Parkinson's
|
Rarely used due to adverse effects in elderly
Improvement in symptoms in 25% of patients; helps mostly with tremors benztropine |